GID_cellular_implant_technology.png
GID_cellular_implant_technology.png

GID Cellular Implant Technology

Introducing an innovative platform technology that provides cellular medicine for multiple significant indications.

GID Technology Overview

Our modular tissue processing platform enables point-of-care therapy for a broad range of indications. By reducing an entire GMP cell-processing facility to a single disposable device, physicians can extract and process adipose tissue in real time using proven scientific methods, controls and reagents. This platform provides scalable cell processing for hospitals, medical practices and other surgical or clinical settings.

Cellular_Implant_Watermark.png
GID_tissue_processing_technology.png

Cellular Implant Benefits

  • Repeatable and predictable
  • Cost-effective
  • Alternative to invasive surgical or drug treatments

Therapeutic Opportunities

GID technology is revolutionizing medicine in three therapeutic domains: musculoskeletal, dermal and organ. There is potential for numerous clinical applications utilizing our cellular implants.

ACTIVci_logo.png

Musculoskeletal

  • Osteoarthritis (OA) knee
  • OA hip/Avascular necrosis (AVN)
  • OA small joints
  • Anterior cruciate ligament (ACL) knee
  • Back/neck
  • Shoulder
  • Tendon/ligament
  • Muscle repair
VIVEci_logo.png

Dermal

  • Peripheral vascular disease
    (PVD) small vessel
  • PVD large vessel
  • Diabetic ulcers
  • Burns/scars
  • Radiation injury
  • Dermal filler
  • Skin rejuvenation
  • Volume augmentation
  • Alopecia
COREci_logo.png

Organ

  • Chronic obstructive pulmonary disease (COPD)
  • Kidney fibrosis
  • Eyes (MD)
  • Eyes (Dry eye)
  • Erectile dysfunction (ED)

Clinical Pipeline

 

Our clinical pipeline features targeted

therapeutic applications and clinical

development in three primary therapeutic

domains.

Clinical Trials

GID clinical trials are in progress for numerous therapeutic applications.

Osteoarthritis: A multisite pivotal clinical trial that is double blinded, randomized, placebo controlled, dose escalated and statistically powered. The trial has investigational device exemption (IDE) approval by the FDA.

Alopecia: An exploratory clinical trial to assess initial safety and feasibility of SVF for hair regeneration in patients with hair loss.

Erectile Dysfunction: A safety and feasibility clinical trial to assess use of SVF for treatment of ED. The trial has IDE approval by the FDA.

COPD: An exploratory clinical trial to assess initial safety and feasibility of SVF for treatment of COPD.

ACTIVci_logo.png

Musculoskeletal

  • Osteoarthritis
VIVEci_logo.png

Dermal

  • PVD/Diabetes
  • Facial filler
  • Breast volume
  • Alopecia
COREci_logo.png

Organ

  • Erectile dysfunction
  • COPD
ACTIVci_logo.png

Musculoskeletal

  • Osteoarthritis
VIVEci_logo.png

Dermal

  • PVD/Diabetes
  • Facial filler
  • Breast volume
  • Alopecia
COREci_logo.png

Organ

  • Erectile dysfunction
  • COPD